Localized ulcerative inflammation of the right dorsal colon often associated with administration of NSAIDs, particularly phenylbutazone or flunixin meglumine; dehydration increases the risk of drug toxicity.
RDC, now preferably called RDUC (U ulcerative), may be associated with the administration of phenylbutazone or other NSAID therapy at the manufacturer's recommended daily dose. The variable toxicity has been attributed to individual variation in response to NSAIDs, duration of treatment, diet composition, health status, age, and hydration status.
Although there is no evidence to demonstrate overrepresentation for any particular age or breed, most reports involve miniature horses, ponies, and young performance horses.
Most cases have a history of administration of oral or parenteral NSAIDs with phenylbutazone being the most commonly used. RDUC can also result following high-dose administration of flunixin meglumine or in combination with phenylbutazone. NSAID therapy is most commonly implemented for treatment of chronic or severe musculoskeletal conditions (i.e. laminitis).
NSAID toxicity results from high-dose therapy, with individual horses having the ability to tolerate higher NSAID administration doses. It is not clear why ulcerative lesions are localized in the right dorsal colon.
With acute disease hematologic abnormalities often include neutropenia with mild to moderate toxic neutrophils in combination with a regenerative or a degenerative left shift. An increased packed cell volume is frequently observed. Patients that present with more chronic disease may have a less pronounced neutropenia, but neutrophil morphology may still reveal toxicity.
Serum biochemical abnormalities often include marked hypoproteinemia, hypochloremia, azotemia and metabolic acidosis. Hypoproteinemia may be observed despite hemoconcentration and will worsen with rehydration. Hypoalbuminemia is common, but when total protein concentration is <4.5 g/dL (45 g/L), panhypoproteinemia is typically observed.
Elevation of total solids concentration and nucleated cell count may be observed.
Exploratory Celiotomy/Laparoscopy
Rarely indicated. Gross examination reveals marked edema, thickening, and/or when the reduced luminal diameter of the intestinal tract is restricted to right dorsal colon.
The treatment consists of discontinuation of NSAID therapy in combination with appropriate supportive therapy.
The majority of patients with RDUC require hospitalization to receive appropriate medical supportive therapy.
Horses with acute disease are treated with supportive treatment, including IV fluids (LRS), systemic broad-spectrum antibiotics, and analgesics. All NSAIDs should be discontinued. When hypoproteinemia is severe (albumin <1.5 g/dL; 15 g/L), plasma transfusion should be administered.
Managements to decrease stress include discontinuing or decreasing or eliminating work such as strenuous exercise.
Surgical intervention indicated when the RDUC cannot be controlled with medical treatment evidenced by recurrent colic episodes. Surgery requires either bypassing or resecting the diseased RDC. Side-to-side colo-colostomy, between the proximal intact part of the RDC and the small colon, can be performed to bypass the diseased part of the RDC. End-to-end colo-colostomy after resection of the diseased RDC can also be performed. The prognosis for horses that undergo surgery is guarded.
Supportive treatment for horses with acute disease includes:
Cook VL, . The use of nonsteroidal anti-inflammatory drugs in critically ill horses. J Vet Emerg Crit Care 2015;25:7688.
Jones SL, , . Ultrasonographic findings in horses with right dorsal colitis: five cases (20002001). J Am Vet Med Assoc 2003;222:12481251.
Karcher LF, , , . Right dorsal colitis. J Vet Intern Med 1990;4:247253.
McConnico RS, , , et al. Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. Am J Vet Res 2008;69:14961505.
Moses VS, . Nonsteroidal anti-inflammatory drugs. Vet Clin North Am Equine Pract 2002;18:2137.